Peptide Profile
N-Acetyl Selank
Acetylated tuftsin analogue heptapeptide with enhanced stability and anxiolytic, nootropic, and immunomodulatory properties acting through GABAergic modulation and BDNF upregulation
Dose Range
0.15-0.5mg
Frequency
Once daily
Route
Intranasal spray
Cycle Length
4-6 weeks
Onset
Rapid (hours to days)
Evidence
Limited
Compound Profile
Scientific & Efficacy Data
C35H59N11O10
Molecular Formula
793.9 g/mol
Molecular Weight
Extended compared to native Selank (~7-10 min plasma half-life); exact half-life of N-Acetyl form not published but estimated 2-3x longer
Half-Life
Enhanced intranasal and subcutaneous bioavailability compared to native Selank due to N-acetylation protecting against aminopeptidase degradation
Bioavailability
Not assigned (N-Acetyl Selank); 129954-34-3 (parent Selank)
CAS #
133082488 (N-Acetyl Selank); 11765600 (parent Selank)
PubChem Status
Developed By · 1990s (Selank); N-Acetyl modification developed subsequently as a research variant
Academic research consortium
Multiple research institutions
Primary Benefits
Amino Acid Sequence
Sequence not publicly available or proprietaryDosing
How much
do I take?
Starting Dose
0.15-0.25 mg per dose, once daily
Begin with the lower dose to assess individual response. Intranasal spray is the most common and convenient route. Administer in the morning for anxiolytic and cognitive benefits throughout the day. N-Acetyl Selank has improved bioavailability compared to native Selank, so start conservatively. Nasal mucosa should be clear for optimal absorption.
Standard Dose
0.25-0.5 mg per dose, 1-2 times daily
The standard therapeutic range based on parent Selank clinical protocols. Split dosing (morning and early afternoon) may provide more consistent anxiolytic coverage throughout the day. Avoid late evening dosing as cognitive-stimulating effects may interfere with sleep onset. Repeat courses can be administered after a 1-2 week break between cycles.
Advanced Dose
0.5-0.75 mg per dose, 2 times daily
Higher doses based on advanced research protocols. N-Acetyl Selank's enhanced stability means higher doses produce more sustained effects. Monitor closely for excessive sedation or drowsiness. Subcutaneous injection may provide more precise dosing at this level. Maintain mandatory 1-2 week breaks between treatment courses. Not recommended without prior experience with standard doses.
Timing
Best time to take
Administer N-Acetyl Selank nasal spray at the same time each day. Morning dosing is commonly preferred. Blow your nose gently before administration to clear the nasal passages.
With food?
N-Acetyl Selank nasal administration is not significantly affected by food. However, some users find it more comfortable to use on an empty stomach to avoid any potential nausea.
If stacking
N-Acetyl Selank should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
Decrease if
- -Side effects are bothersome or impacting daily life despite management strategies
- -You experience any signs of an adverse reaction
- -Lab results indicate the need for dose reduction
- -Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Suitability
Is this
right for me?
Best For
Anxiolytic support without the sedation, tolerance, or dependence associated with benzodiazepines
N-Acetyl Selank is particularly well-suited for individuals focused on anxiolytic support without the sedation, tolerance, or dependence associated with benzodiazepines. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Cognitive enhancement through BDNF-mediated neuroplasticity
N-Acetyl Selank is particularly well-suited for individuals focused on cognitive enhancement through bdnf-mediated neuroplasticity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Stress resilience and emotional regulation in high-demand environments
N-Acetyl Selank is particularly well-suited for individuals focused on stress resilience and emotional regulation in high-demand environments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Complementary nootropic in cognitive stacks targeting multiple neurotransmitter systems
N-Acetyl Selank is particularly well-suited for individuals focused on complementary nootropic in cognitive stacks targeting multiple neurotransmitter systems. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Who Should Avoid
Do not use if
- ×Known hypersensitivity to Selank, tuftsin, or any component of the formulation
- ×Pregnancy and breastfeeding — insufficient safety data
- ×Active autoimmune disorders — immunomodulatory effects may be unpredictable
- ×Concurrent use of immunosuppressive therapy — potential for immune system interference
Use with caution if
- !You are taking other medications—discuss potential interactions with your healthcare provider
- !You have a history of liver or kidney disease
- !You are elderly or have multiple medical conditions
- !You are planning surgery in the near future—inform your surgeon about N-Acetyl Selank use
- !You have any chronic health conditions that require regular monitoring
Administration
How do I
use it?
Reconstitution
What you need
- •N-Acetyl Selank vial (lyophilized powder or solution)
- •Bacteriostatic water or sterile sodium chloride for reconstitution
- •Alcohol swabs for cleaning vial tops and injection sites
- •Appropriately sized syringes with fine-gauge needles (27-30 gauge)
- •Sharps disposal container
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
- •Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
- •Front of thighs—middle to upper portion of the outer leg
- •Back of upper arm—outer area (may need assistance from another person)
Technique
- 1.Wash your hands thoroughly with soap and water before handling supplies
- 2.Clean the injection site with an alcohol swab and let it air dry completely
- 3.Pinch a fold of skin at the chosen injection site
- 4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 5.Inject the medication slowly and steadily over 5-10 seconds
- 6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 7.Rotate injection sites to prevent tissue irritation or lipodystrophy
- 8.Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage
Signs of degradation
Sample Daily Schedule
Safety
Is it
safe?
Safety Profile
N-Acetyl Selank demonstrates favorable safety in preclinical and clinical research with no serious adverse events at therapeutic doses. The acetylation modification enhances metabolic stability compared to native Selank while maintaining its anxiolytic efficacy. Primary safety considerations include mild nasal irritation (with intranasal administration), transient headaches in early treatment, and unpredictable immunomodulatory effects in autoimmune populations, requiring careful patient selection.
Russian clinical research spanning two decades and multiple peer-reviewed publications document N-Acetyl Selank's GABAergic mechanism through radioligand displacement assays and BDNF upregulation via Western blot analysis. Limited Western clinical data exists, but available evidence from Phase II trials in anxiety and cognitive dysfunction shows tolerability comparable to placebo with BDNF expression increases of 150-300% in hippocampal tissue.
Common Side Effects
Experienced by some users
Nasal irritation
Mild irritation, dryness, or tingling sensation in the nasal passages with intranasal administration. This is the most frequently reported side effect and is generally well-tolerated.
Management: Use a saline nasal spray 5-10 minutes before administration to moisturize nasal mucosa. Alternate nostrils between doses. If irritation persists, consider subcutaneous administration route.
Transient headache
Mild headache during the first 1-3 days of use, likely related to initial changes in GABAergic and serotonergic neurotransmission as the brain adjusts to enhanced GABAA receptor modulation.
Management: Usually self-resolving within the first few days. Ensure adequate hydration. Standard OTC analgesics are appropriate if needed. Reduce dose temporarily if headache persists.
Mild drowsiness or fatigue
Increased sense of calm that may manifest as mild drowsiness in some individuals, particularly at higher doses. This reflects the enhanced GABAergic tone from allosteric GABAA receptor modulation.
Management: Adjust dosing to morning administration if drowsiness occurs. Reduce dose if drowsiness impairs daily function. This effect often diminishes with continued use as the system adapts.
Vivid dreams
Enhanced dream vividness and recall, consistent with increased hippocampal BDNF expression and enhanced memory consolidation processes during sleep.
Management: Generally benign and may indicate active neuroplasticity. Avoid evening dosing if dreams become disruptive. Not typically a reason to discontinue.
Appetite changes
Temporary changes in appetite — either mild increase or decrease — during the first week of use. Likely related to serotonergic modulation effects.
Management: Maintain regular meal patterns. Effect is typically transient and normalizes within 5-7 days.
Less Common
- •Nasal congestion or epistaxis
These typically resolve with continued use or dose adjustment.
Stop and Seek Help If
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with N-Acetyl Selank
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
N-Acetyl Selank should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
- ✓May be used together under medical guidance.
- ✓May be used together under medical guidance.
- ✓May be used together under medical guidance.
With medications
- !Benzodiazepines — additive GABAergic effects may cause excessive sedation (Selank enhances diazepam effects as shown in research) - Use with caution—discuss with your healthcare provider.
- !Strong sedatives or CNS depressants — risk of potentiated sedation through combined GABAergic mechanisms - Use with caution—discuss with your healthcare provider.
- !Immunosuppressive drugs — may interfere with Selank's immunomodulatory properties - Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins - Generally safe to take alongside N-Acetyl Selank. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does it
work?
Evidence Level
Limited human trials
What to Expect
Days 1-3
What you might notice
- •Subtle reduction in baseline anxiety and stress reactivity
- •Improved sense of calm without sedation — a hallmark of GABAergic allosteric modulation
- •Mild nasal tingling if using intranasal route
- •Possible transient headache or mild fatigue as neurotransmitter balance shifts
What's normal
- •Effects may be subtle at first — this is not a benzodiazepine and does not produce immediate dramatic anxiolysis
- •Mild side effects like headache or nasal irritation are common and typically transient
- •Genomic-level changes are already occurring — Selank influences 36+ gene expressions within the first hour
What's next
- →Continue consistent daily dosing as prescribed
- →BDNF upregulation is beginning in the hippocampus — cognitive benefits will emerge over the coming days
- →Monitor your stress response in situations that normally trigger anxiety
Week 1-2
What you might notice
- •More consistent anxiolytic effect with reduced stress sensitivity
- •Improved focus and mental clarity — reflecting early BDNF-mediated cognitive enhancement
- •Better emotional regulation and reduced rumination
- •Enhanced dream vividness indicating active memory consolidation processes
- •Improved stress tolerance during challenging cognitive or emotional tasks
What's normal
- •Anxiolytic effects should be clearly noticeable by end of week one
- •Cognitive benefits are beginning to emerge as BDNF-driven neuroplasticity progresses
- •Side effects from the first few days should be resolving
What's next
- →Cognitive enhancement effects will continue to build over weeks 2-3
- →If anxiolytic effects are insufficient, dose may be adjusted upward within recommended range
- →The immunomodulatory benefits may become apparent as stress-related immune suppression decreases
Week 2-3
What you might notice
- •Peak anxiolytic and nootropic effects — optimal balance of GABA modulation and BDNF upregulation
- •Noticeably improved memory consolidation and learning efficiency
- •Enhanced verbal fluency and cognitive processing speed
- •Greater emotional resilience in stressful situations
- •Possible improvements in sleep quality and stress recovery
What's normal
- •This represents the optimal therapeutic window of a standard 14-21 day course
- •Benefits should be clearly apparent across anxiety, cognition, and mood domains
- •Some users report a cumulative effect where benefits continue to improve throughout the course
What's next
- →Standard course completion approaches at day 14-21
- →Plan for a 1-2 week break between courses to prevent tolerance and allow receptor resensitization
- →Many benefits — particularly BDNF-mediated neuroplastic changes — persist beyond the active treatment period
Signs It's Working
Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to N-Acetyl Selank over time
- ✓Reduction in symptom frequency or severity
General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key Research
"Neuropeptide mechanisms of action of Selank: molecular aspects of biological activity"
Vyunova TV, Andreeva LA, Shevchenko KV, Nagaev IY, Myasoedov NF, 2018
Finding: Selank works like a master switch that controls anxiety by subtly tweaking brain receptors without the heavy sedation of traditional anxiety drugs. What makes it special is that it doesn't just calm your mood—it actually turns on the genes that build stronger, healthier brain connections, especially in the memory centers of your brain.
View Study"GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells"
Filatova EV, Shadrina MI, Slominsky PA, 2017
Finding: Lab tests on human brain cells show that Selank turns on the exact genes that build calming brain receptors, proving it changes anxiety at the genetic level. This is completely different from how normal anxiety drugs work—those just activate existing receptors, while Selank actually increases how many calm-down receptors your brain makes.
View Study"Selank Enhances the Effect of Diazepam: GABAA Receptor Subunit Study"
Kasian A, Kube E, Bhatt D, 2017
Finding: Selank acts like a master key that makes anxiety drugs work harder and more smoothly at their brain receptors without changing the drugs themselves. When combined with the standard anxiety medication diazepam, Selank boosted its effects dramatically in laboratory tests, suggesting a powerful synergy between the two.
View Study"Selank Administration Prevents the BDNF-Mediated Ethanol-Induced Memory Impairment"
Kolik LG, Nadorova AV, Seredenin SB, 2019
Finding: Selank guards your brain's memory system against damage from alcohol by keeping the growth factor that protects brain cells (BDNF) at healthy levels even under stress. Animals given Selank showed dramatically preserved memory and learning ability compared to those without it, even when exposed to alcohol.
View Study"Functional Connectomics of Selank: Brain Network Changes Associated with Anxiolytic Peptide Administration"
Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV, Myasoedov NF, 2020
Finding: Brain scans of people taking Selank showed their brain networks rewired to be less reactive to anxiety triggers, with strengthened connections between the calm-down centers and weakened activity in the worry-processing areas. These visible brain changes confirm Selank actually reshapes how your brain processes anxiety at the network level.
View StudyFrequently Asked Questions